Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,923,488
+$553,131 QoQ
Shares Held
35,136
+2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,181
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. JNJ ranks #5 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,923,488 | 35,136 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,370,357 | 34,243 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,940,894 | 33,539 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,702,034 | 30,752 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,855,922 | 31,790 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,356,465 | 32,299 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,803,263 | 33,213 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,508,742 | 33,992 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $5,499,561 | 37,627 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $5,987,964 | 37,853 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,826,808 | 37,175 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,582,078 | 35,840 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $6,217,592 | 37,564 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,897,440 | 38,048 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $6,833,703 | 38,685 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $9,285,871 | 56,843 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $9,910,203 | 55,829 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $9,647,158 | 54,433 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $9,193,984 | 53,744 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $8,766,866 | 54,284 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $8,961,195 | 54,396 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $9,147,555 | 55,659 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $9,374,495 | 59,566 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $9,620,923 | 64,622 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $9,983,040 | 70,988 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $9,403,593 | 71,712 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||